Latest Advances

  • Condition: Early Triple Negative Breast Cancer
  • Journal: Critical reviews in oncology/hematology
  • Treatment Used: Immunotherapy Addition to Neoadjuvant Chemotherapy (NACT)
  • Number of Patients: 1496
  • Published —
This review of the literature examined the use of neoadjuvant chemo-immunotherapy in the treatment of patients with early triple negative breast cancer (TNBC).
  • Condition: Early Stage Triple Negative Breast Cancer
  • Journal: BMC cancer
  • Treatment Used: Capecitabine-Based Neoadjuvant and Adjuvant Chemotherapy
  • Number of Patients: 3842
  • Published —
This meta analysis evaluated how capecitabine in neoadjuvant and adjuvant chemotherapy effects survival in early-stage triple-negative breast cancer (TNBC) patients.
  • Condition: Metastatic Breast Cancer
  • Journal: Nature medicine
  • Treatment Used: Durvalumab
  • Number of Patients: 29
  • Published —
The study researched the usage of durvalumab for treating metastatic breast cancer.
  • Condition: Early-Stage Triple-Negative Breast Cancer
  • Journal: JAMA
  • Treatment Used: Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency
  • Number of Patients: 443
  • Published —
The aim of this study was to evaluate the effectiveness and adverse effects of low-dose capecitabine maintenance after standard adjuvant chemotherapy in early-stage triple-negative breast cancer.
  • Condition: Women Aged 70 Years or Older with Triple-Negative Breast Cancer
  • Journal: The Lancet. Oncology
  • Treatment Used: Addition of Chemotherapy to Local Therapy
  • Number of Patients: 16062
  • Published —
This study explored the effect of adding chemotherapy to local therapy on overall survival in older women with triple-negative breast cancer.
  • Condition: Locally Advanced Triple Negative Breast Cancer
  • Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]
  • Treatment Used: Neoadjuvant Apatinib in Combination with Dose-dense Paclitaxel and Carboplatin
  • Number of Patients: 17
  • Published —
In this study, researchers evaluated the outcomes of using neoadjuvant apatinib in combination with dose-dense paclitaxel and carboplatin for the treatment of locally advanced triple negative breast cancer.
  • Condition: Triple-negative Breast Cancer
  • Journal: The Journal of international medical research
  • Treatment Used: Platinum-based Neoadjuvant Chemotherapy
  • Number of Patients: 1345
  • Published —
In this study, researchers evaluated the outcomes of using platinum-based neoadjuvant chemotherapy for the treatment of triple-negative breast cancer.
  • Condition: Triple-Negative Metastatic Breast Cancer (mTNBC)
  • Journal: The Cochrane database of systematic reviews
  • Treatment Used: Platinum-Containing Regimens
  • Number of Patients: 0
  • Published —
This review of the literature assessed the effects of platinum-containing chemotherapy regimens with regimens not containing platinum in the treatment of women with metastatic triple-negative breast cancer (mTNBC).
  • Condition: Early-Stage Triple-Negative Breast Cancer
  • Journal: Lancet (London, England)
  • Treatment Used: Atezolizumab with Nab-Paclitaxel and Chemotherapy
  • Number of Patients: 455
  • Published —
The study researched the outcomes of atezolizumab with nab-paclitaxel and chemotherapy for patients with early-stage triple-negative breast cancer.
  • Condition: Triple-Negative Breast Cancer (TNBC)
  • Journal: Complementary therapies in medicine
  • Treatment Used: Chinese Medicine TCM Formula
  • Number of Patients: 256
  • Published —
This study examined the effect of triple-negative breast cancer (TNBC) on two-year disease-free survival rate with or without Chinese medicine TCM formula.
  • Condition: Triple-negative Breast Cancer
  • Journal: International journal of molecular sciences
  • Treatment Used: Metformin and Gefitinib
  • Number of Patients: 0
  • Published —
The study researched different treatment methods targeting different areas for triple-negative breast cancer.
Showing 1-12 of 118